Healthcare denial management is always challenging, to the point that many providers work with a range of medical billing and coding services to make sure they’re keeping their denials low and optimizing cash flows. But since the COVID-19 pandemic, many elements of the denial management process have shifted.
On May 17, 2022, the U.S. Food and Drug Administration (FDA) amended the Pfizer-BioNTech COVID-19 vaccine emergency use authorization (PDF) to authorize the use of a single booster pediatric dose (orange cap) for all patients 5 – 11 years old. The Centers for Medicare & Medicaid Services (CMS) issued a new code, effective May 17, 2022, for the vaccine administration.
While many organizations were figuring out how to go remote during the pandemic, healthcare revenue cycle management teams were pioneering virtual work. Since hospitals had to stay open, revenue cycle teams were some of the first workers to figure out how to make remote work. But even before that, coders were already working remotely. Today, many hospital leaders have leaned into the efficiency and benefits of remote work – but there are still challenges. This article will walk you through some of those challenges, as well as tips on how to step into the future of remote work for your hospital revenue cycle management team.
The American Medical Association (AMA) announced an editorial update to Current Procedural Terminology (CPT), that includes newly assigned provisional CPT codes for COVID-19 booster candidates from Pfizer and Sanofi-GlaxoSmithKline.
On March 29, the Food and Drug Administration (FDA) authorized a second Moderna COVID-19 vaccine booster dose for adults aged 50 and older and certain immunocompromised adults. Following this, the Centers for Medicare & Medicaid Services (CMS) released Current Procedural Terminology (CPT) codes for reporting the second Moderna COVID-19 booster on medical claims.
